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OBJECTIVE — Evidence has shown that Mexican Americans have a higher prevalence of
diabetes and a greater risk for diabetes-related complications than non-Hispanic whites. How-
ever, no studies have described the changes in prevalence among older Mexican Americans. The
purposeofthisstudywastoexpandonthecurrentliteraturebyexaminingthetrendsindiabetes
prevalence and diabetes-related complications in Mexican Americans aged 75 years from
1993–1994 to 2004–2005.
RESEARCH DESIGN AND METHODS — The prevalences of self-reported diabetes
and diabetes-related complications were estimated in the original cohort (1993–1994) and the
newcohort(2004–2005)oftheHispanicEstablishedPopulationfortheEpidemiologicStudyof
the Elderly (Hispanic EPESE) and were compared across the two surveys.
RESULTS — The prevalence of diabetes among Mexican Americans aged 75 years has
nearly doubled between 1993–1994 and 2004–2005 from 20.3 to 37.2%, respectively (P 
0.001). The increase in the prevalence of diabetes was similar across all sociodemographic
factors. Diabetes complications did not change signiﬁcantly between the two cohorts. However,
the prevalence of having any lower-extremity function disability did increase between the two
cohorts.
CONCLUSIONS — The prevalence of diabetes in older Mexican Americans has increased
dramatically.Atthesametime,therehasbeennoimprovementindiabetes-relatedcomplications
ashasbeenfoundinthegeneralolderpopulation.Theseﬁndingsheightentheurgencyformore
effective public health interventions targeted to this population. As diabetes and obesity become
more prevalent in older adults, physicians should encourage appropriate management in older
patients, including early detection and glycemic control.
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D
iabetes is the seventh leading cause
of death in the U.S., affecting 16.8
million Americans in 2006 (1). The
prevalence of diabetes among individuals
aged 75 years is projected to increase
336% by 2050 (2). This upward trend is
attributed mainly to the aging of the pop-
ulation, an increase in obesity, and life-
style changes (3–5). Simultaneously,
there has been a decrease in the preva-
lence of several diabetes-related compli-
cations as a result of advancements in
diabetes management (6).
OlderHispanicsarearapidlygrowing
segment of the U.S. population (7). Dur-
ing 1999 and 2002, diabetes was diag-
nosed in 24.9% of older Mexican
Americans (aged 65 years) compared
with only 14.3% of non-Hispanic white
adultsofthesameage(8).MexicanAmer-
icansalsohaveanincreasedriskandprev-
alence of diabetes-related complications
and a higher disability rate compared
with non-Hispanic whites (9,10). As
overall life expectancy has increased,
many Mexican Americans are living
longerwithmorecomorbiditiesincluding
diabetes (9). Although several studies
have examined the national trends of di-
abetesoverthepreviousdecades,nostud-
ies have examined the trends in diabetes
prevalence and diabetes-related compli-
cations among older Mexican Americans.
Hence, the purpose of this study was to
expandonthecurrentliteraturebyexam-
ining the trends in diabetes prevalence
and diabetes-related complications over
the period 1993–1994 to 2004–2005,
comparing two separate representative
samples from the Hispanic Established
Population for the Epidemiologic Study
of the Elderly (Hispanic EPESE), a com-
munity-based study of older Mexican
Americans (aged 65 years) residing in
ﬁve southwestern states. This analysis
builds on earlier work with the baseline
data from this study, which showed high
rates of diabetes and diabetes complica-
tions in older Mexican Americans in
1993–1994 (11–14).
RESEARCH DESIGN AND
METHODS— Data from the original
cohort surveyed in 1993–1994 and the
new cohort surveyed in 2004–2005 of
the Hispanic EPESE, a community-based
study of older noninstitutionalized Mexi-
can Americans residing in ﬁve southwest-
ern states (Texas, California, Arizona,
Colorado, and New Mexico) were com-
pared.TheoriginalcohortoftheHispanic
EPESE included a total of 3,050 Mexican
Americans aged 65 years. This cohort
was selected through multistage area
probability sampling of selected counties,
blocks, and households, ensuring that
the results could be generalizable to
500,000 older Mexican Americans.
Speciﬁc sampling procedures describing
the Hispanic EPESE are available else-
where (15). The response rate in 1993–
1994 was 83%. Of that sample, a total of
1,132 subjects were aged 75 years. In
theﬁfthwaveconductedin2004–2005,a
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75 years was added, using sampling
proceduressimilartothoseusedin1993–
1994. Interviews were conducted in En-
glish and Spanish, depending on the
subjects’ preference. Our study included
subjects both from the original cohort in
1993–1994 and from the new cohort in
2004–2005 who were aged 75 years.
This process resulted in two independent
samples of Mexican Americans aged 75
years for analyses.
Measurement of diabetes
Respondentswerecodedashavingdiabe-
tes in 1993–1994 and 2004–2005 if they
reportedthattheyhadbeentoldbyadoc-
tor that they had diabetes, sugar in their
urine, or high blood glucose or if they
were found to be taking hypoglycemic
drugs in an inspection of the medications
they had taken in the 2 weeks before the
interview.
Diabetes-related complications
Diabetes-related complications examined
were microvascular complications, in-
cluding kidney disease and visual impair-
ment, and macrovascular complications,
including circulatory disease and periph-
eral circulatory problems. Functional dis-
ability was also assessed. Kidney disease
was determined by the following ques-
tion: “As a result of your diabetes, have
youeverhadanyproblemswithyourkid-
neys?” Visual impairment was deter-
mined by the following question: “As a
result of your diabetes, have you ever had
any problems with your eyes?” Peripheral
circulatorydiseasewasdeterminedbythe
following question: “As a result of your
diabetes,haveyoueverhadanyproblems
withthecirculationinyourlegsorarms?”
Subjects were determined to have cardio-
vascular disease if they reported ever hav-
ing a heart attack or a stroke.
Functional disability was ascertained
through several self-reported variables.
Lower-extremity function was measured
by walking in a small room, walking a
half-mile, walking up and down stairs,
and transferring from bed to a chair.
These items were examined separately
and also summed to form a dichotomous
variable indicating any lower-body dis-
ability. Also available was a measure of
activities of daily living (ADL), which as-
sessed disability by asking the subjects if
they needed assistance with one or more
ofthefollowingtasks:bathing,grooming,
dressing, eating, transferring, or toileting.
Instrumental activities of daily living
(IADL) disability was assessed by asking
the respondents if they needed assistance
with one or more of the following tasks:
usingatelephone,driving,shopping,pre-
paringmeals,doinglighthousework,tak-
ing medicine, or handling money. Both
ADL and IADL disability were dichoto-
mized, indicating any ADL and IADL dis-
ability separately.
Demographic and health-related
characteristics
Other covariates included in the analyses
were age, years of education, sex, obesity,
hypertension, and number of physicians’
visits in the past year. Age was dichoto-
mized as 75–79 years and 80 years.
Self-reportedhypertensionwasmeasured
by asking whether a physician had ever
told the respondents that they had high
blood pressure. BMI was calculated from
the respondent’s measured height and
weight. BMI was categorized as 24, 25–
29,and30kg/m
2.Numberofphysician
visits in the year before the interview was
assessed by standard questions.
Statistical methods
Descriptive analyses of the sample were
conducted using means and 95% CIs for
continuous variables and proportions for
categorical variables. Comparisons were
made using the Rao-Scott 
2 test for cat-
egorical variables and t test statistics for
continuous variables. Diabetes preva-
lence and the prevalence of diabetes-
related complications and functional
disability were estimated in both cohorts
andcomparedusingtheRao-Scott
2test.
We used SAS (version 9.2) survey proce-
dures software to perform all analyses to
account for design effects and sample
weights.
RESULTS
Descriptive characteristics of the
samples in 1993–1994 and
2004–2005
Table 1 presents the descriptive charac-
teristics of the full sample of Mexican
Americans aged 75 years in both 1993–
1994and2004–2005.Theaverageeduca-
tional attainment increased signiﬁcantly
betweenthetwosamplesfrom4.3yearsin
the original cohort to 5.3 years in the new
cohort (P  0.003). There was a signiﬁ-
cantincreaseinthenumberofindividuals
withMedicareandprivateinsurancefrom
17.0 to 25.4% (P  0.049). Obesity rates
also increased between 1993–1994 and
2004–2005 from 20.3 to 28.9% (P 
0.001). Moreover, self-reported hyper-
tension increased signiﬁcantly between
the two cohorts from 36.6 to 56.7%, re-
spectively (P  0.001). Characteristics
such as age, sex, and physicians’ visits did
not change signiﬁcantly between the two
time periods.
Table 1—Descriptive characteristics of total sample by time period (unweighted frequencies
and weighted percents)
1993/1994 2004/2005
P n % n %
n 1,132 902
Age (years)* 1,132 81.0 (80.7–81.3) 902 81.4 (80.1–81.7) 0.357
Education (years)* 1,109 4.3 (4.1–4.5) 902 5.3 (4.7–5.3) 0.003
Female sex 662 58.4 531 59.6 0.639
Physician visits* 1,070 6.6 (6.1–7.2) 881 7.4 (6.7–8.0) 0.708
Type of insurance
No insurance 71 7.4 52 5.8
Medicare only 438 37.4 249 28.8 0.049
Medicare and Medicaid
or Medicaid only 438 38.2 388 40.0
Private and Medicare 185 17.0 213 25.4
BMI
25 kg/m
2 383 38.5 243 32.1
25–29 kg/m
2 368 41.2 287 39.0 0.007
30 kg/m
2 225 20.3 187 28.9
Self-report hypertension 394 36.6 503 56.7 0.001
Data are n or % unless indicated otherwise. n  2,030. The n presented is the sample n due to missing data.
*Data are means (95% CI).
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Table 2 presents the prevalence rate of
diabetes at each time period as well as the
prevalence of diabetes within the covari-
ate strata. The overall prevalence of dia-
betes increased from 20.3% in 1993–
1994 to 37.2% in 2004–2005 (P 
0.001). Moreover, the prevalence of dia-
betes has uniformly increased across all
demographic characteristics, which in-
clude sex, age, and education subgroups.
For example, the increase in diabetes
prevalence was statistically signiﬁcant for
eachagecategory.An18.9(95%CI11.1–
26.7) percentage point increase was ob-
served in subjects aged 75–79 years and a
15.2 (8.2–22.2) percentage point in-
crease was observed for subjects aged
80 years between these periods.
The prevalence of diabetes increased
since1993–1994regardlessofhealthcare
usage represented by physicians’ visits,
health insurance, BMI, and self-reported
hypertension. Speciﬁcally, the prevalence
of diabetes increased across all categories
of physicians’ visits, with the largest in-
crease occurring in the ﬁve or more visits
categoryfrom26.2%(95%CI20.7–31.7)
in 1993–1994 to 47.5% (41.0–54.1) in
2004–2005 (P  0.001). Similarly, the
prevalenceofdiabetesincreasedacrossall
types of insurance with the largest in-
crease in prevalence of diabetes among
those with Medicare and Medicaid or
Medicaid only (P  0.001). The preva-
lence of diabetes among overweight (BMI
25–29 kg/m
2) Mexican Americans more
than doubled from 16.9% in 1993–1994
to40.3%in2004–2005(P0.001).The
prevalence of diabetes among obese (BMI
30 kg/m
2) Mexican Americans almost
doubled from 27.3% in 1993–1994 to
46.9% in 2004–2005 (P  0.001).
Inaddition,Table2showsprevalence
rates within each covariate strata and
sample year. In both cohorts signiﬁcant
differences in the prevalence of diabetes
were shown for obesity and self-reported
hypertension. In 1993–1994 the preva-
lence of diabetes was higher among obese
compared with nonobese subjects (27.3
and 17.8%, respectively). A similar pat-
tern was also present in 2004–2005. In
addition, in the 1993–1994 cohort the
prevalence of diabetes among those who
reported hypertension was higher com-
pared with that for those who did not re-
port hypertension (25.3 and 16.4%,
respectively). This pattern was echoed in
2004–2005.
Prevalence of diabetes-related
complications and disability
Table 3 indicates the prevalence of diabe-
tes-related complications and functional
disability among Mexican Americans in
both cohorts. The mean age of the 1993–
1994 cohort was 80.4 (95% CI 79.9–
81.0) and in the 2004–2005 cohort the
mean age was 80.5 (80.0–80.9). No sta-
tistically signiﬁcant differences were
foundbetweenthetwocohorts;therefore,
the estimates of diabetes-related compli-
cationswerenotageadjusted.Noneofthe
microvascular or macrovascular compli-
cations signiﬁcantly increased between
the two time periods. On the other hand,
having any lower-extremity functional
Table2—Prevalenceofdiabetesbydemographicandhealth-relatedcharacteristicsin1993/1994and2004/2005(unweightedfrequenciesand
weighted percents), n  2,034
1993/1994 2004/2005
Difference % (95% CI) P n % (95% CI) n % (95% CI)
1,132 902
Overall 242/1,132 20.3 (17.0–23.6) 324/902 37.2 (32.9–41.6) 17.0 (11.5–22.4) 0.001
Sex
Male 100/469 20.2 (15.5–24.8) 122/371 34.5 (28.4–40.7) 14.3 (6.6–22.0) 0.001
Female 142/660 20.3 (16.0–24.7) 202/530 39.1 (33.8–44.4) 18.7 (11.9–25.6) 0.001
Age
75–79 years 116/520 20.8 (16.2–25.4) 157/399 39.7 (33.4–46.0) 18.9 (11.1–26.7) 0.001
80 years 126/609 19.8 (15.4–24.3) 167/502 35.1 (29.7–40.5) 15.2 (8.2–22.2) 0.001
Education
0–6 years 187/855 20.3 (16.4–24.2) 224/604 39.5 (35.2–43.8) 19.2 (13.4–25.1) 0.001
7 years 52/251 21.6 (15.0–28.3) 100/397 33.0 (25.8–40.2) 11.3 (1.48–21.1) 0.022
Physician visits
0–1 visits 23/227 9.5 (4.9–14.0) *20/123 21.0 (13.1–29.0)* 11.6 (2.4–20.7) 0.006
2–4 visits 60/317 19.4 (13.8–25.1) 99/320 32.3 (25.2–39.3) 12.8 (3.8–21.9) 0.003
5 visits 151/525 26.2 (20.7–31.7) 202/437 47.5 (41.0–51.1) 21.3 (12.8–29.9) 0.001
Type of insurance
No insurance 11/70 16.8 (4.3–29.4) 13/52 27.3 (14.4–40.3) 10.5 (7.6–28.5) 0.260
Medicare only 87/437 17.9 (13.6–22.2) 85/248 35.6 (26.9–44.4) 17.7 (8.0–27.4) 0.001
Medicare and/or Medicaid only 101/437 23.4 (17.6–29.1) 158/388 41.6 (36.3–46.9) 18.2 (10.4–26.0) 0.001
Private and Medicare 43/185 20.1 (12.5–27.7) 68/213 34.5 (26.4–42.6) 14.4 (3.3–25.5) 0.006
BMI
25 kg/m
2 65/383 18.8 (13.0–24.6)* 61/243 23.6 (17.5–29.6)* 4.8 (3.6–13.2) 0.271
25–29 kg/m
2 74/368 16.9 (12.1–21.7) 111/287 40.3 (33.1–47.4) 23.4 (14.7–32.0) 0.001
30 kg/m
2 63/225 27.3 (21.2–33.5) 83/186 46.9 (38.2–55.6) 19.6 (8.9–30.2) 0.001
Self-reported hypertension
Yes 113/394 25.3 (20.5–32.0)* 274/503 46.4 (40.4–52.4)* 20.1 (11.8–28.4) 0.001
No 118/697 16.4 (12.7–20.1) 87/382 25.1 (20.3–29.9) 8.7 (2.7–14.8) 0.002
Data are n or % (95% CI). *Signiﬁcant difference between all covariate strata in each cohort (P  0.05).
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bed (P  0.005), and ADL disability in-
creased among individuals with diabetes
(P  0.047).
CONCLUSIONS — This is the ﬁrst
study that examined trends of diabetes
and diabetes-related complications
among Mexican Americans aged 75
years. The prevalence of diabetes in this
sample increased from 20.3% in 1993–
1994 to 37.2% in 2004–2005. The prev-
alence of both microvascular and
macrovascular diabetes complications
andIADLdisabilitydidnotchangesignif-
icantly between the two cohorts. How-
ever, the prevalence of having any lower-
extremity disability did increase between
thetwocohorts.Inaddition,self-reported
ADLdisabilityalsosigniﬁcantlyincreased
among individuals with diabetes between
the two time periods.
Our ﬁndings are consistent with pre-
vious reports showing a national contin-
uousupwardtrendindiabetesprevalence
over the previous decade. Reports from
the Centers for Disease Control and Pre-
ventionhaveshownthattheprevalenceof
diabetes among the general population
aged 75 years increased from 10.4% in
1993to16.4%in2005(1).UsingtheNa-
tional Health Interview Survey (NHIS),
the Centers for Disease Control and Pre-
vention estimated the prevalence of dia-
betes among Mexican Americans aged
75 years in 2005 to be 28.5% (SEM
3.6),whichwassomewhatlowerthanour
estimateof37%for2004–2005(2.2)(1).
Our data show no signiﬁcant changes
in diabetes-related visual impairment
among individuals with diabetes over the
period from 1993–1994 to 2004–2005.
This is consistent with national ﬁndings
fromtheNHISindicatinganonsigniﬁcant
change in visual impairment rates among
individuals with diabetes aged 75 years
from 32.4% (SEM 2.0) in 1997 to 27.1%
(1.4) in 2007 (1). Studies report a de-
creaseindiabetes-relatedvisualproblems
between the 1980s and the beginning of
the 21st century resulting from improve-
ments in screening and glycemic control
(6). This improvement may not be appar-
ent in our study because of differences in
study periods compared with other stud-
ies, the advanced age of our sample, and
measures used.
Although no prevalence data for dia-
betes-related kidney problems have been
reported, ﬁndings from the U.S. Renal
DataSystemshowedthatincidencerateof
end-stagerenaldisease(ESRD)amongin-
dividuals with diabetes aged 75 years
hasincreasedsigniﬁcantlyovertheperiod
from 1997 to 2002, whereas it decreased
among those aged 65 years (16). It is
important to consider that our estimates
measure any kidney disease related to di-
abetes, not ESRD speciﬁcally. The in-
crease shown in ESRD presented in
previous reports among those aged 75
years is again probably due to the in-
creased survival of individuals with dia-
betes. Moreover, it could also reﬂect a
concomitant increase in referral, admis-
sionrates,andinterventionratherthanan
actual increase in ESRD incidence (6).
Similar to the trends in microvascular
complications, we did not ﬁnd signiﬁcant
changes in the prevalence of macrovascu-
lar complications including cardiovascu-
lar disease and peripheral circulatory
problems. These ﬁndings are similar to
reports from the NHIS showing no signif-
icantchangesintheprevalenceofanycar-
diovascular disease among the general
population aged 75 years over the pe-
riod from 1997 to 2003 (1). Because ma-
crovascular conditions are not strongly
related to hyperglycemia, improvement
in diabetes management might not mod-
ify the prevalence of these conditions
among individuals with diabetes (17).
The higher prevalence of diabetes re-
portedinthisstudymightbepartlydueto
changes in the diagnostic criteria. The
cutoff point in glycemia for a diagnosis of
diabetes was decreased from 140 to
126 mg/dl in 1997 (18). This reduction
may have had a substantial inﬂuence on
the recent prevalence estimates for diabe-
tes. The new diagnostic criteria are prob-
ably capturing individuals with diabetes
at an earlier point in the disease. Reports
havesuggestedthatwidespreaduseofthe
new criteria are capturing many individ-
uals with undiagnosed diabetes, which
Table 3—Prevalence of diabetes-related complications and disability among Mexican Americans with diabetes aged >75 years in 1993/1994
and 2004/2005 (unweighted frequencies and weighted percents)
1993/1994 2004/2005
Difference % (95% CI) P n % (95% CI) n % (95% CI)
Microvascular complications
Any complication 135/220 57.7 (48.9–66.6) 170/320 51.3 (43.2–59.4) 6.5 (18.5 to 5.6) 0.292
Kidney disease 29/218 13.9 (7.4–20.4) 44/314 14.6 (9.3–19.9) 0.75 (7.6 to 9.1) 0.861
Visual impairment 85/213 38.3 (29.6–46.9) 113/312 36.4 (29.9–42.9) 1.86 (12.7 to 9.0) 0.735
Macrovascular complications
Circulatory disease 92/215 39.2 (30.9–47.5) 128/305 40.5 (31.0–50.0) 1.31 (11.3 to 14.0) 0.838
Cardiovascular disease 71/240 28.0 (21.7–34.2) 80/319 27.1 (19.8–34.4) 0.87 (8.8 to 10.5) 0.859
Self-report functional disability
Walking 52/240 22.1 (15.2–28.9) 101/323 32.2 (24.1–40.3) 10.2 (0.048 to 20.8) 0.056
Walking half-mile 107/235 39.3 (30.6–47.9) 135/317 43.2 (35.4–50.9) 3.9 (7.7 to 15.6) 0.508
Walking upstairs 114/238 47.2 (39.2–55.2) 134/319 43.2 (36.0–50.4) 4.0 (6.7 to 14.8) 0.456
Transferring from bed 38/240 15.4 (9.8–21.1) 110/323 32.2 (23.0–41.5) 16.8 (6.0 to 27.6) 0.005
Any lower-extremity disability 181/235 75.2 (66.9–83.6) 267/319 85.0 (80.1–89.9) 9.8 (0.013 to 19.4) 0.031
Global functional disability
ADL disability 75/241 29.5 (22.1–36.9) 141/324 41.5 (31.9–51.2) 12.1 (0.010 to 24.2) 0.047
IADL disability 182/242 77.3 (69.6–85.0) 263/324 80.2 (72.5–88.0) 2.9 (8.0 to 13.8) 0.284
Data are n or % (95% CI). n  566.
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mates (18).
Another explanation for the upward
trend in diabetes is the concurrent in-
crease in obesity in older Mexican Amer-
icans. As we have shown above, the
prevalence of obesity has increased dra-
matically in this older population since
the baseline interview in 1993–1994.
Obesity is reported to be one of the most
signiﬁcant factors contributing to the de-
velopment of diabetes and is highly prev-
alent in Hispanic populations (19).
Mexican Americans are living longer
but are living with more chronic condi-
tionsandmoredisability(9).Olderadults
with diabetes are more likely to have
functional disabilities and are more likely
to use mobility aids compared with indi-
viduals without diabetes (20). Conse-
quently, more functional disability
among individuals with diabetes could
also lead to an overall reduction in active
life expectancy.
Active life expectancy is an important
consideration because the prevalence of
diabetes has dramatically increased
among Mexican Americans aged 75
years. It has been found that individuals
with diabetes aged 75 years in the U.K.
have experienced a signiﬁcant reduction
in active life expectancy in recent years,
where individuals without diabetes had
an extra 2 years of life without disability
compared with individuals with diabetes
in1999(21).Similarly,astudyconsisting
of older adults aged 65 years showed
that those who do not have diabetes gain
between 4 and 5 disability-free years of
life (22). Both diabetes and obesity con-
tributetoareductioninfunctionalability.
Older adults who are obese are more
likely to become disabled and, generally
speaking, older adults are also less likely
to recover compared with younger obese
individuals (23). As Mexican Americans
age, speciﬁc attention to the pathways
leading to this increase in obesity such as
the reduction of adipose tissue in the ab-
dominal area and dietary modiﬁcations
could reduce functional disability and in-
crease future active life expectancy.
There are several limitations to this
study.Thedeterminationofadiabetesdi-
agnosiswasbasedonaself-reportedmea-
sure and was not based on any clinical
measure of fasting plasma glucose. In ad-
dition, the presence of diabetes-related
complications was also based on self-
report. However, these types of self-
reported measures have been found to
be a valid and reliable method of deter-
mining the presence of disease (24).
Nevertheless, underreporting may have
occurred by not including those in whom
diabetes has not yet been diagnosed, but
whoactuallyhavethedisease.IntheU.S.,
it is estimated that there are 2.4 million
individuals with undiagnosed diabetes.
Moreover, many diagnoses are incidental
and only occur when related complica-
tions emerge. New onset of diabetes in
older individuals is not very common,
meaning that oftentimes diabetes goes
undiagnosed while other complications
arise (25).
In summary, in light of the high preva-
lenceofdiabetesinthisgroup,noimprove-
ment in diabetes-related complications
heightens the urgency for public health
interventions. As diabetes is projected to
become more prevalent in older adults in
the future (2), physicians need to be
trained in early detection of diabetes
amongolderadultsandshouldencourage
appropriate management in patients aged
75 years, including glycemic control
and healthier lifestyles and adequate
pharmacological treatment when indi-
cated. Moreover, common clinical and
physiological pathways between obesity
and diabetes may allow the development
of interventions that might improve dia-
betes-related complications and func-
tional disability in this population.
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